JETEMA THE TOXIN
Live / Registered — Registered (as of 11 Aug 2020)
What this means for you
Registered since 11 Aug 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79260523
- Registration number
- 6121081
- Mark type
- Word mark
- Filed
- 30 Apr 2019
- Published for opposition
- 26 May 2020
- Registered
- 11 Aug 2020
- Attorney of record
- Kisuk Lee
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical agents affecting sensory organs; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for urogenital organs; anti-inflammatory and antipyretic preparations; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; ophthalmic preparations; allergy medications; pharmaceutical agents for epidermis; pharmaceutical preparations acting on the central nervous system; analgesics; pharmaceutical preparations for respiratory organs; medicines for dental purposes; Pharmaceutical preparations used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for facial aesthetic surgery, facial aesthetic reconstruction; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations and medicines for the treatment and prevention of sexual dysfunction; Pharmaceutical preparations and medicines for the treatment of sensory organ disorders; Pharmaceutical preparations and medicines for the treatment of central nervous system disorders; Pharmaceutical preparations and medicines for the treatment of urogenital organ disorders; Pharmaceutical preparations and medicines for the treatment of circulatory system disorders; Pharmaceutical preparations and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression; neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism
Owner
- JETEMA CO., LTD., KR
- JETEMA CO., LTD., KR
- JETEMA CO., LTD., KR
Prosecution history
- 11 Aug 2025 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 19 Dec 2020 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 01 Dec 2020 — FINAL DISPOSITION NOTICE SENT TO IB
- 01 Dec 2020 — FINAL DISPOSITION PROCESSED
- 11 Nov 2020 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 11 Aug 2020 — REGISTERED-PRINCIPAL REGISTER
- 29 May 2020 — NOTIFICATION PROCESSED BY IB
- 26 May 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 May 2020 — PUBLISHED FOR OPPOSITION
- 13 May 2020 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 13 May 2020 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 06 May 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Apr 2020 — ASSIGNED TO LIE
- 08 Apr 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Apr 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED